SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heavy selling pressure as investors scrutinize the company's aggressive debt-funded AI infrastructure expansion and potential concentration risk related to OpenAI. While the community remains divided between those viewing the steep price decline as a capitulation-driven buying opportunity and others concerned about long-term management strategy and capital allocation, sentiment is heavily influenced by intense algorithmic volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending as the community debates whether the stock is a long-term play on financial infrastructure or a victim of increasing competition from traditional payment giants like Visa and Mastercard. While bullish investors point to potential breakthroughs from the Clarity Act and institutional adoption, others are actively trading based on significant volatility and technical gap-fill levels.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense community debate driven by its recent inclusion in the Russell 3000 index and ongoing speculation surrounding potential defense-sector supercycles and counter-drone contract opportunities. While bulls are focused on the company's autonomous systems partnerships and backlog growth, the stock is experiencing significant volatility as market participants clash over the impact of recent share dilution and heavy short interest.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors rotate into clean energy infrastructure following a strategic 380MW data center power deal that signals a shift from project proposals to active commercial execution. The community is actively debating the company's valuation gap compared to peers, while monitoring management's ability to convert pipeline demand into binding backlog and sustainable revenue.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is experiencing significant volatility and trading momentum driven by a strong re-rating as investors pivot the stock toward an AI data center power infrastructure narrative. While the community is actively debating the sustainability of these gains versus potential short-squeeze dynamics, bullish sentiment is being further fueled by recent insider buying from the CEO and speculative interest in the company's new solid-state transformer technology.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to significant institutional accumulation and speculation surrounding its obesity pipeline, particularly as the market monitors upcoming Q3 maintenance study data. Community discussion is heavily focused on potential M&A activity, with long-term holders debating the likelihood of a buyout as the company progresses its VK2735 and VK3019 programs against sector heavyweights.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining significant momentum as investors digest recent leadership additions and anticipate the official initiation of the global Phase 3 AURORA trial for non-small cell lung cancer. Community sentiment remains highly bullish, with active discussions focusing on the company's potential to disrupt the oncology market, the strategic value of its immune-activating platform, and the possibility of future acquisition by major pharmaceutical players.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following a significant earnings beat and record backlog growth, which investors are weighing against soft forward guidance and margin concerns. The community is actively debating the stock's long-term potential in the defense drone super-cycle, with bullish sentiment focused on autonomous warfare demand while bears point to valuation risks and recent share price volatility.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is surging as its new Rev8 digital lidar sensors and BlueCity traffic management platform secure high-profile deployments, including infrastructure support for the 2026 FIFA World Cup and major industrial contracts. Investors are actively debating the company's transition into a key supplier for the physical AI and robotics ecosystem, highlighting its growing role as a Western-certified infrastructure provider.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently experiencing intense downward pressure as investors react to management's cautious commentary on its Watchman growth outlook, leading to a significant breakdown in price. The community is actively debating whether this represents a long-term value opportunity bolstered by ongoing share repurchases or a sign of deeper structural issues, with many traders looking for a capitulation point to enter a relief bounce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action

$EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action $EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action PR Newswire NEW YORK, June 30, 2026 A securities fraud...

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit PR Newswire NEW YORK, June 29, 2026 NEW YORK, June 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces...

Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC

Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC PR Newswire LOS ANGELES, June 29, 2026 LOS ANGELES, June 29, 2026 /PRNewswire/ --The...

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ANGELES, June 29, 2026 LOS ANGELES, June 29, 2026 /PRNewswire/ --The Schall...

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) common stock between November 25...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming...

Deadline Approaching: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) common stock between November 25, 2025 and May 4, 2026, inclusive...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm EncouragesEmbecta Corp. (EMBC) Shareholders To Inquire About Securities Fraud Class Action

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) common stock between November 25...

EMBC UPCOMING DEADLINE: Levi & Korsinsky Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm

EMBC UPCOMING DEADLINE: Levi & Korsinsky Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm EMBC UPCOMING DEADLINE: Levi & Korsinsky Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm PR Newswire NEW YORK, June 24, 2026 Time-Sensitive...

EMBC Breaking Class Action Lawsuit: Embecta Sued for Securities Fraud after Insulin Pen Issues Lead to 57% Stock Drop Investors Notified to Contact BFA Law

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ:EMBC) and certain of the Companys senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal...

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Embecta Corp

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.26
Prev Close	$3.31
Open	$3.31
Dividend Yield	4.25%
50-Day Moving Average	$4.70
Beta	0.88
Avg. Volume	3.92M
PE Ratio	1.74

52-Week High	$15.55
52-Week Low	$2.77
Market Capitalization	$196.37M
EPS (Annual)	$1.62
Price to Book	-0.31
Revenue Per Employee	$584,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

EMBCEmbecta Corp

Latest EMBC News